Gogleva, Anna
Polychronopoulos, Dimitris http://orcid.org/0000-0001-9427-3082
Pfeifer, Matthias
Poroshin, Vladimir
Ughetto, Michaël
Martin, Matthew J.
Thorpe, Hannah
Bornot, Aurelie
Smith, Paul D. http://orcid.org/0000-0002-2812-5978
Sidders, Ben
Dry, Jonathan R. http://orcid.org/0000-0002-1640-2616
Ahdesmäki, Miika
McDermott, Ultan http://orcid.org/0000-0001-9032-4700
Papa, Eliseo
Bulusu, Krishna C. http://orcid.org/0000-0002-5092-6640
Article History
Received: 25 August 2021
Accepted: 9 March 2022
First Online: 29 March 2022
Competing interests
: The authors declare the following competing interests. All authors except M.P. and H.T. were full-time employees and shareholders of AstraZeneca at the time of study. M.P. and H.T. were PostDoc Fellows of the AstraZeneca PostDoc program at the time when experiments were completed. J.D.’s current affiliation is Tempus Labs, Cambridge MA. E.P.’s current affiliation is DeepMind, London, UK.